PubRank

Laurent Savale

Author PubWeight™ 37.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 2011 7.21
2 Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 2012 2.87
3 Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009 2.73
4 Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med 2008 1.71
5 Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis. Chest 2010 1.48
6 Left ventricular ejection time in acute heart failure complicating precapillary pulmonary hypertension. Chest 2013 1.39
7 RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med 2009 1.28
8 HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010 1.27
9 Pulmonary arterial hypertension. Orphanet J Rare Dis 2013 1.18
10 Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Adv Ther 2009 1.10
11 Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol 2011 1.08
12 Pulmonary veno-occlusive disease: recent progress and current challenges. Respir Med 2010 1.06
13 Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Eur Heart J 2010 1.01
14 Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil. Rheumatology (Oxford) 2009 0.96
15 Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol 2007 0.95
16 Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats. Circulation 2010 0.93
17 Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study. J Heart Lung Transplant 2011 0.90
18 Pulmonary hypertension in patients with neurofibromatosis type I. Medicine (Baltimore) 2011 0.90
19 Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2. Chest 2015 0.85
20 Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension. Respir Med 2010 0.84
21 Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother 2011 0.82
22 Drugs induced pulmonary arterial hypertension. Presse Med 2013 0.82
23 Mediastinal fibrosis mimicking proximal chronic thromboembolic disease. Circulation 2012 0.78
24 Pulmonary Hypertension Complicating Fibrosing Mediastinitis. Medicine (Baltimore) 2015 0.78
25 Drug-induced pulmonary arterial hypertension: a recent outbreak. Eur Respir Rev 2013 0.77
26 [Pulmonary arterial hypertension]. Rev Prat 2008 0.76
27 Ventilation/perfusion lung scan in pulmonary veno-occlusive disease. Eur Respir J 2011 0.76
28 Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy. Eur Respir J 2013 0.75
29 A study of magnesium deficiency in human and experimental pulmonary hypertension. Magnes Res 2012 0.75
30 Should we screen for pulmonary hypertension at the initial evaluation of idiopathic pulmonary fibrosis? Respiration 2013 0.75
31 Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension. Am J Cardiovasc Drugs 2015 0.75